{"id":"W4283587187","doi":"10.1136/annrheumdis-2022-eular.4280","title":"OP0017 RECAPTURE RATES WITH IXEKIZUMAB AFTER WITHDRAWAL OF THERAPY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS AT WEEK 104 FROM A RANDOMIZED PLACEBO-CONTROLLED WITHDRAWAL STUDY","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Placebo; Ankylosing spondylitis; Mallinckrodt; Internal medicine; Randomized controlled trial; Disease; Secukinumab; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003432694,0.001327212,0.003617429,0.0004494005,0.0004375612,0.001031184,0.0008307995,0.001547126,0.00232606],"category_scores_gemma":[0.003128465,0.0005398824,0.002864753,0.0004715963,0.0009859218,0.001106803,0.0004375865,0.002372648,0.0005010826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006901934,"about_ca_system_score_gemma":0.0006610438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005511199,"about_ca_topic_score_gemma":0.0006209429,"domain_scores_codex":[0.9983391,0.0008068985,0.0001631663,0.0002555258,0.0002258487,0.0002094152],"domain_scores_gemma":[0.9978485,0.0006806548,0.0007390376,0.0002637516,0.0001725201,0.0002955667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9421801,0.006284423,0.007097299,0.0006023999,0.002186273,0.00008499143,0.0001090059,0.0002840918,0.008350739,0.00003686049,0.000398695,0.03238524],"study_design_scores_gemma":[0.5343395,0.3818807,0.07277208,0.00008753957,0.00421165,0.0002385771,0.0001351243,0.0008970551,0.00426374,0.0001366617,0.0009592425,0.00007795693],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968339,0.002085685,0.000179253,0.00007769244,0.00007091012,0.0002977563,0.0002143427,0.00001866924,0.000221816],"genre_scores_gemma":[0.9976253,0.0007184466,0.0002234618,0.0001408055,0.0001201861,0.0002963882,0.0003665526,0.00001140176,0.0004974107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003617429,"threshold_uncertainty_score":0.01815403,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01074701420255621,"score_gpt":0.2481301580780922,"score_spread":0.2373831438755359,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}